 | |
| |
Announcement that Insmed has discontinued its internal development of INS-1, one of its investigational drug candidates for type 2 diabetes and polycystic ovary syndrome (PCOS).
| |||||||||
| |
| ||||||||
| |||||||||
Copyright © 1997-2008 HealthBoard.com
| |
|
| |
Announcement that Insmed has discontinued its internal development of INS-1, one of its investigational drug candidates for type 2 diabetes and polycystic ovary syndrome (PCOS).
| |||||||||
| |
| ||||||||
| |||||||||
Copyright © 1997-2008 HealthBoard.com